Sort
85,873 grants matching “alzheimers”
Alzheimer's DIsease Research Center
$2,023,516Steven T Dekosky · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · AG
ALZHEIMER'S DISEASE RESEARCH CENTER
$2,023,491Duke University · P50 · FY2002 · AG
Mechanisms of Activity-dependent Microglia-neuron Interactions in Development and Disease
$2,022,102Beth Ann Stevens · Boston Children'S Hospital · RF1 · FY2023 · NS
Interstitial fluid flow in Alzheimer's Disease Progression
$2,021,966Jennifer M Munson · Virginia Polytechnic Inst And St Univ · RF1 · FY2021 · AG
Elevated mitochondrial fusion and function in Down syndrome
$2,021,900Beverly A. Rothermel · Ut Southwestern Medical Center · R01 · FY2019 · HD
Social and Environmental Determinants of Health Equity
$2,021,420Chandra Jackson · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
New computational tools for understanding and predicting AD via age-associated DNA methylation changes
$2,020,719Lily Wang · University Of Miami School Of Medicine · RF1 · FY2022 · NS
Microbiome Multi-Omics and Cognitive Decline in Latinos
$2,020,674Natalia Palacios · University Of Massachusetts Lowell · RF1 · FY2023 · AG
Imaging Pathophysiology in Aging and Neurodegeneration
$2,020,576William E Klunk · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AG
Genetic Consortium for Late Onset Alzheimer's Disease
$2,020,374Columbia University Health Sciences · U24 · FY2005 · AG
Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions
$2,019,855Xiangmin Xu · University Of California-Irvine · R01 · FY2024 · AG
New Approaches to Dementia Heterogeneity
$2,019,770Bruce L Miller · University Of California, San Francisco · P50 · FY2012 · AG
New Approaches to Dementia Heterogeneity
$2,019,359Bruce L Miller · University Of California, San Francisco · P50 · FY2014 · AG
Carboxyl-terminal modulator protein, Aβ and brain aging
$2,018,750Ian Christopher Wenker · University Of Virginia · RF1 · FY2019 · AG
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate
$2,018,653D. Martin Watterson · Neurokine Therapeutics, Llc · R42 · FY2019 · AG
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
$2,018,428Claudia H. Kawas · University Of California-Irvine · R01 · FY2015 · AG
Leveraging novel mouse models to investigate toxic metal exposures on brain aging and Alzheimer's disease
$2,018,294Lee E Goldstein · Boston University Medical Campus · U01 · FY2025 · AG
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD cohort
$2,018,181Marilyn S Albert · Johns Hopkins University · U01 · FY2013 · AG
New Approaches to Dementia Heterogeneity
$2,017,997Bruce L Miller · University Of California, San Francisco · P50 · FY2016 · AG
The Frontotemporal Lobar Degeneration Neuroimaging Initiative
$2,017,781Howard J Rosen · University Of California, San Francisco · R01 · FY2012 · AG
Mayo Clinic Metabolomics Resource Core
$2,017,609K. Sreekumaran Nair · Mayo Clinic Rochester · U24 · FY2014 · DK
Neuroimaging Predictors of Cognitive Decline and Impairment
$2,016,758Susan Resnick · National Institute On Aging · ZIA · FY2013 · AG
Genetic characterization of atypical parkinsonism
$2,016,541Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Genetic Consortium for Late Onset Alzheimer's Disease
$2,016,312Richard Mayeux · Columbia University Health Sciences · U24 · FY2008 · AG
Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes
$2,015,979Ann Carolyn McKee · Boston University Medical Campus · U54 · FY2021 · NS